{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:10:21Z","timestamp":1791598221137,"version":"4.3.4"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.19029","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T15:01:39Z","timestamp":1603983699000},"page":"e2019029","source":"Crossref","is-referenced-by-count":52,"title":["Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland"],"prefix":"10.1001","volume":"3","author":[{"given":"Heidi","family":"Taipale","sequence":"first","affiliation":[{"name":"Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio"},{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"University of Eastern Finland School of Pharmacy, Kuopio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"S\u00e4rkil\u00e4","sequence":"additional","affiliation":[{"name":"Turku University Hospital, Department of Psychiatry, University of Turku, Turku, Finland"},{"name":"City of Turku Welfare Division, Turku City Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Tanskanen","sequence":"additional","affiliation":[{"name":"Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio"},{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Kurko","sequence":"additional","affiliation":[{"name":"Research Unit, The Social Insurance Institution, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero","family":"Taiminen","sequence":"additional","affiliation":[{"name":"Turku University Hospital, Department of Psychiatry, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[{"name":"Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio"},{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"},{"name":"Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reijo","family":"Sund","sequence":"additional","affiliation":[{"name":"University of Eastern Finland School of Medicine, Kuopio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamari","family":"Tuulio-Henriksson","sequence":"additional","affiliation":[{"name":"Department of Psychology and Logopedics, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Saastamoinen","sequence":"additional","affiliation":[{"name":"Research Unit, The Social Insurance Institution, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmo","family":"Hietala","sequence":"additional","affiliation":[{"name":"Turku University Hospital, Department of Psychiatry, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"issue":"September","key":"zoi200672r1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.psychres.2017.09.059","article-title":"Prescribing practices in Southeastern Europe\u2014focus on benzodiazepine prescription at discharge from nine university psychiatric hospitals.","volume":"258","author":"Maric","year":"2017","journal-title":"Psychiatry Res"},{"issue":"4","key":"zoi200672r2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1017\/ipm.2016.24","article-title":"How do we compare with best practice? a completed audit of benzodiazepine and z-hypnotic prescribing.","volume":"35","author":"Rowntree","year":"2018","journal-title":"Ir J Psychol Med"},{"issue":"February","key":"zoi200672r3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review.","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi200672r4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eurpsy.2011.11.003","article-title":"Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? a critical reappraisal.","volume":"28","author":"Dell\u2019osso","year":"2013","journal-title":"Eur Psychiatry"},{"issue":"2","key":"zoi200672r5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/bcp.2014.77.issue-2","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"zoi200672r6","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/add.2011.106.issue-12","article-title":"Benzodiazepines revisited\u2014will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"issue":"6","key":"zoi200672r8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/jsr.2017.26.issue-6","article-title":"European guideline for the diagnosis and treatment of insomnia.","volume":"26","author":"Riemann","year":"2017","journal-title":"J Sleep Res"},{"key":"zoi200672r11","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"5","key":"zoi200672r12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.","volume":"28","author":"Baldwin","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"5","key":"zoi200672r13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00406-014-0563-z","article-title":"The German guidelines for the treatment of anxiety disorders.","volume":"265","author":"Bandelow","year":"2015","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"11","key":"zoi200672r14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/archpsyc.1989.01810110035005","article-title":"Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder: 2.5 year naturalistic follow-up study.","volume":"46","author":"Nagy","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"zoi200672r15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ajp.2013.12101353","article-title":"A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.","volume":"171","author":"Pollack","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"1","key":"zoi200672r16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/appi.ajp.2013.13101304","article-title":"Treatment in nonresponsive patients with social anxiety: back to the future with benzodiazepines.","volume":"171","author":"Roy-Byrne","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"11","key":"zoi200672r17","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1586\/14737175.2014.963057","article-title":"The reappraisal of benzodiazepines in the treatment of anxiety and related disorders.","volume":"14","author":"Starcevic","year":"2014","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"zoi200672r18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/14656566.2018.1472767","article-title":"Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review.","volume":"19","author":"Gomez","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"zoi200672r19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/15622975.2018.1500031","article-title":"Benzodiazepines in anxiety disorders: reassessment of usefulness and safety.","volume":"20","author":"Rickels","year":"2019","journal-title":"World J Biol Psychiatry"},{"issue":"8","key":"zoi200672r20","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns\u2014a systematic review of register-based studies.","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur Psychiatry"},{"key":"zoi200672r21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jpsychires.2017.11.012","article-title":"What can predict and prevent the long-term use of benzodiazepines?","volume":"97","author":"Hata","year":"2018","journal-title":"J Psychiatr Res"},{"issue":"4","key":"zoi200672r22","doi-asserted-by":"publisher","first-page":"371.e11","DOI":"10.1016\/j.jamda.2017.12.098","article-title":"Fall-risk\u2013increasing drugs: a systematic review and meta-analysis, II: psychotropics.","volume":"19","author":"Seppala","year":"2018","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"zoi200672r23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00198-013-2446-y","article-title":"Association between use of benzodiazepines and risk of fractures: a meta-analysis.","volume":"25","author":"Xing","year":"2014","journal-title":"Osteoporos Int"},{"issue":"4","key":"zoi200672r24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174730","article-title":"Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis.","volume":"12","author":"Donnelly","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"zoi200672r25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/gps.v33.4","article-title":"Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: a matched cohort study.","volume":"33","author":"Saarelainen","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2-3","key":"zoi200672r26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.healthpol.2010.03.008","article-title":"Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use.","volume":"97","author":"Cunningham","year":"2010","journal-title":"Health Policy"},{"issue":"8","key":"zoi200672r27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002635","article-title":"Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: a total population register-linkage study.","volume":"15","author":"Sidorchuk","year":"2018","journal-title":"PLoS Med"},{"issue":"6","key":"zoi200672r28","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/pds.v27.6","article-title":"Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: a national register study for 2006 to 2014.","volume":"27","author":"Kurko","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"zoi200672r29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/bdi.12626","article-title":"Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder.","volume":"20","author":"Wing\u00e5rd","year":"2018","journal-title":"Bipolar Disord"},{"issue":"2","key":"zoi200672r30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1176\/appi.ps.201300066","article-title":"Trends in anxiolytic-hypnotic use and polypharmacy in Taiwan, 2002-2009: a nationwide, population-based survey.","volume":"65","author":"Wang","year":"2014","journal-title":"Psychiatr Serv"},{"issue":"12","key":"zoi200672r31","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/pds.v26.12","article-title":"Trends in utilization of benzodiazepine and Z-drugs in Israel.","volume":"26","author":"Berman","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"zoi200672r32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12911-015-0140-z","article-title":"From prescription drug purchases to drug use periods\u2014a second generation method (PRE2DUP).","volume":"15","author":"Tanskanen","year":"2015","journal-title":"BMC Med Inform Decis Mak"},{"issue":"3","key":"zoi200672r33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00228-011-1124-2","article-title":"Use of addictive anxiolytics and hypnotics in a national cohort of incident users in Norway.","volume":"68","author":"Kjosavik","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"zoi200672r34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029641","article-title":"Factors associated with long-term prescription of benzodiazepine: a retrospective cohort study using a health insurance database in Japan.","volume":"9","author":"Takano","year":"2019","journal-title":"BMJ Open"},{"issue":"11","key":"zoi200672r35","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1001\/jamainternmed.2018.2413","article-title":"Factors associated with long-term benzodiazepine use among older adults.","volume":"178","author":"Gerlach","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"4","key":"zoi200672r36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/YIC.0000000000000080","article-title":"Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer\u2019s disease.","volume":"30","author":"Taipale","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"key":"zoi200672r37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.psychres.2016.01.040","article-title":"Continuation and discontinuation of benzodiazepine prescriptions: a cohort study based on a large claims database in Japan.","volume":"237","author":"Takeshima","year":"2016","journal-title":"Psychiatry Res"},{"issue":"6","key":"zoi200672r38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000353198","article-title":"Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis.","volume":"82","author":"Offidani","year":"2013","journal-title":"Psychother Psychosom"},{"issue":"4","key":"zoi200672r39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000491524","article-title":"Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review.","volume":"87","author":"Fava","year":"2018","journal-title":"Psychother Psychosom"},{"issue":"4","key":"zoi200672r40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2165\/00003088-199121040-00003","article-title":"Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations (part II).","volume":"21","author":"Greenblatt","year":"1991","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"zoi200672r41","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2174\/138920011796504473","article-title":"Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems.","volume":"12","author":"Trifir\u00f2","year":"2011","journal-title":"Curr Drug Metab"},{"key":"zoi200672r42","first-page":"7","article-title":"Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.","volume":"65","author":"Chouinard","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"zoi200672r43","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/fcp.2011.25.issue-5","article-title":"Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network.","volume":"25","author":"Frauger","year":"2011","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"zoi200672r44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0376-8716(91)90044-Y","article-title":"Physical dependence on benzodiazepines: differences within the class.","volume":"29","author":"Wolf","year":"1991","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi200672r45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/ADM.0000000000000350","article-title":"A review of alprazolam use, misuse, and withdrawal.","volume":"12","author":"Ait-Daoud","year":"2018","journal-title":"J Addict Med"},{"issue":"2","key":"zoi200672r46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States.","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"zoi200672r47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s001270200006","article-title":"Different study criteria affect the prevalence of benzodiazepine use.","volume":"37","author":"Zandstra","year":"2002","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"zoi200672r48","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2147\/CLEP","article-title":"Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons.","volume":"8","author":"Taipale","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"11","key":"zoi200672r49","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00228-007-0349-6","article-title":"High concordance between self-reported medication and official prescription database information.","volume":"63","author":"Haukka","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"zoi200672r7","unstructured":"National Institute for Health and Care Excellence. Generalised Anxiety Disorder and Panic Disorder in Adults: Management. National Institute for Health Care and Excellence; 2011. Clinical guideline [CG113]. Updated July 26, 2019. Accessed September 17, 2020. https:\/\/www.nice.org.uk\/guidance\/cg113"},{"key":"zoi200672r9","unstructured":"National Institute for Health Care and Excellence. Do Not Do Recommendations. Accessed February 9, 2020. https:\/\/www.nice.org.uk\/media\/default\/sharedlearning\/716_716Donotdobookletfinal.pdf"},{"key":"zoi200672r10","unstructured":"Valvira. Benzodiazepine Prescribing Guideline. Updated June 17, 2020. Accessed September 28, 2020. https:\/\/www.valvira.fi\/terveydenhuolto\/hyva-ammatinharjoittaminen\/laakehoito\/bentsodiatsepiinien_maaraaminen_2"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2772339\/taipale_2020_oi_200672_1603374698.84832.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T15:02:32Z","timestamp":1603983752000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2772339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.19029","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]}}}